Jiajin Biopharmaceutical (Shanghai) Co., Ltd.
PrivateLast Round
Series B++
Jun 5, 2026
Total Funding Raised
$6.29M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Jiajin Biopharmaceutical (Shanghai) Co., Ltd. is a biotechnology company that specializes in antibody-small nucleic acid coupled drugs and brain-delivery platforms for the treatment of genetic and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jiajin Biopharmaceutical (Shanghai) Co., Ltd. Comparables
Compare Jiajin Biopharmaceutical (Shanghai) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aerska | 83% | |
| Gate2Brain | 80% | |
| Vect-Horus | 78% | |
Jiajin Biopharmaceutical (Shanghai) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B++ | Jun 5, 2026 | ||||
| Series B Extension | Dec 26, 2025 | ||||
| Series B | Aug 19, 2025 | ||||
| Series A++ | Apr 3, 2025 | ||||
| Series A Extension | Nov 8, 2024 | ||||
Series A | Jun 15, 2024 |
Jiajin Biopharmaceutical (Shanghai) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Science and Technology Innovation Group | Series B++ |
| Legend Capital | Series B Extension, Series B++ |
| Frees Fund | Series B++, Angel |
| Sunshine Insurance Group | Series B++, Series B |
| MPC | Series B++, Angel |
| Lilly Asia Ventures | Series B++ |
| Qingsong Capital | Series B++ |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 26, 2025
Raised Series B Extension with Legend Capital and YuanBio Venture Capital.
- Apr 3, 2025
YuanBio Venture Capital participated in the round.
Jiajin Biopharmaceutical (Shanghai) Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Jiajin Biopharmaceutical (Shanghai) Co., Ltd.'s valuation, stock price, and market status.